Bml Capital Management, LLC Verrica Pharmaceuticals Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 180,000 shares of VRCA stock, worth $1.56 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
180,000
Previous 180,000
-0.0%
Holding current value
$1.56 Million
Previous $1.32 Billion
19.13%
% of portfolio
0.71%
Previous 1.0%
Shares
3 transactions
Others Institutions Holding VRCA
# of Institutions
61Shares Held
16.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY7.1MShares$61.5 Million0.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY4MShares$34.7 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.27MShares$11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.11MShares$9.66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.9 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $356M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...